Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-12

FDA Approved: FML — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for FML (fluorometholone), resulting in updated labeling for the ophthalmic corticosteroid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FML (Fluorometholone)

Snippet

SUPPL AP for FML (FLUOROMETHOLONE)